Rehmann Capital Advisory Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $2.44K | Buy |
355
+49
| +16% | +$337 | ﹤0.01% | 1375 |
|
|
2019
Q2 | $2.82K | Sell |
306
-9,582
| -97% | -$88.4K | ﹤0.01% | 1708 |
|
|
2019
Q1 | $155K | Sell |
9,888
-3,672
| -27% | -$57.6K | 0.02% | 473 |
|
|
2018
Q4 | $209K | Buy |
13,560
+3,746
| +38% | +$57.8K | 0.03% | 245 |
|
|
2018
Q3 | $211K | Buy |
9,814
+795
| +9% | +$17.1K | 0.03% | 385 |
|
|
2018
Q2 | $219K | Buy |
9,019
+5,201
| +136% | +$126K | 0.03% | 356 |
|
|
2018
Q1 | $65K | Buy |
+3,818
| New | +$65K | 0.01% | 670 |
|
|
2017
Q1 | – | Sell |
-6,096
| Closed | -$221K | – | 405 |
|
|
2016
Q4 | $221K | Sell |
6,096
-503
| -8% | -$18.2K | 0.04% | 346 |
|
|
2016
Q3 | $304K | Sell |
6,599
-146
| -2% | -$6.73K | 0.06% | 255 |
|
|
2016
Q2 | $339K | Sell |
6,745
-222
| -3% | -$11.2K | 0.06% | 233 |
|
|
2016
Q1 | $373K | Buy |
6,967
+86
| +1% | +$4.6K | 0.07% | 211 |
|
|
2015
Q4 | $452K | Sell |
6,881
-115
| -2% | -$7.55K | 0.09% | 166 |
|
|
2015
Q3 | $395K | Buy |
6,996
+202
| +3% | +$11.4K | 0.09% | 176 |
|
|
2015
Q2 | $402K | Sell |
6,794
-139
| -2% | -$8.23K | 0.09% | 181 |
|
|
2015
Q1 | $432K | Sell |
6,933
-88
| -1% | -$5.48K | 0.1% | 176 |
|
|
2014
Q4 | $404K | Buy |
7,021
+740
| +12% | +$42.6K | 0.09% | 187 |
|
|
2014
Q3 | $338K | Buy |
6,281
+369
| +6% | +$19.9K | 0.08% | 209 |
|
|
2014
Q2 | $310K | Sell |
5,912
-945
| -14% | -$49.6K | 0.07% | 227 |
|
|
2014
Q1 | $362K | Buy |
+6,857
| New | +$362K | 0.1% | 170 |
|